1.
Rashid Lui 雷諾信
@RashidLui
What is VOROPRAZAN???
Is it going be your treatment of choice for erosive esophagitis?
Should it?
...a wher… twitter.com/i/web/status/1…
Is it going be your treatment of choice for erosive esophagitis?
Should it?
...a wher… twitter.com/i/web/status/1…
Retweet of status by @laura_targownik
27 Dec 22
copy & paste +upvote -downvote What is VOROPRAZAN???
Is it going be your treatment of choice for erosive esophagitis?
Should it?
...a 🧵wher… https://t.co/CLwDQsmUuM
2.
Rashid Lui 雷諾信
@RashidLui
1/10 It's #EBGI Tweetorial w/ @aileenbui!
“Tiny Polyps – It’s OK to Remove Polyps ≤3mm with Large Biopsy Forcep… twitter.com/i/web/status/1…
“Tiny Polyps – It’s OK to Remove Polyps ≤3mm with Large Biopsy Forcep… twitter.com/i/web/status/1…
Retweet of status by @AmCollegeGastro
14 Sep 22
copy & paste +upvote -downvote 1/10 It's #EBGI Tweetorial 🧵 w/ @aileenbui!
“Tiny Polyps – It’s OK to Remove Polyps ≤3mm with Large Biopsy Forcep… https://t.co/zVghBavQtG
3.
4.
5.
6.
7.
Rashid Lui 雷諾信
@RashidLui
#IDDF2022 We are delighted to announce the winners of the JGH-IDDF Case/Video Champion 2022:
Ka-Shing Cheng (HK)
… twitter.com/i/web/status/1…
Ka-Shing Cheng (HK)
… twitter.com/i/web/status/1…
Retweet of status by @IDDF_CUHK
03 Sep 22
copy & paste +upvote -downvote #IDDF2022 We are delighted to announce the winners of the JGH-IDDF Case/Video Champion 2022:
🏅Ka-Shing Cheng (HK)
🏅… https://t.co/cRTEPquunA
Rashid Lui 雷諾信
@RashidLui
Dabigatran-induced exfoliative esophagitis
dabigatran pellets are covered with a tartaric acid core.
This s… twitter.com/i/web/status/1…
dabigatran pellets are covered with a tartaric acid core.
This s… twitter.com/i/web/status/1…
Retweet of status by @KMonkemuller
20 Aug 22
copy & paste +upvote -downvote 💊 Dabigatran-induced exfoliative esophagitis
✅ dabigatran pellets are covered with a tartaric acid core.
✅ This s… https://t.co/NImDYKmTYN
Rashid Lui 雷諾信
@RashidLui
The 2023-24 @ASCO Leadership Development Program Asia-Pacific is now open for application!
Mid-career oncology… twitter.com/i/web/status/1…
Mid-career oncology… twitter.com/i/web/status/1…
03 Aug 22
copy & paste +upvote -downvote 📢 The 2023-24 @ASCO Leadership Development Program Asia-Pacific is now open for application!
✅ Mid-career oncology… https://t.co/USsvg7LMoA
Rashid Lui 雷諾信
@RashidLui
Tuesday 24th, 9:15 am Don't miss the #WATERFALLtrial international RCT interim analysis, aggressive versus modera… twitter.com/i/web/status/1…
Retweet of status by @DeMadaria
16 May 22
copy & paste +upvote -downvote Tuesday 24th, 9:15 am 👉🏼Don't miss the #WATERFALLtrial international RCT interim analysis, aggressive versus modera… https://t.co/2AAwhYTkPF
Rashid Lui 雷諾信
@RashidLui
3 signs of pneumoperitoneum in one AXR #GITwitter #MedEd
Hyperlucent liver sign (*) - dark gas over the nor… twitter.com/i/web/status/1…
Hyperlucent liver sign (*) - dark gas over the nor… twitter.com/i/web/status/1…
Retweet of status by @drkeithsiau
10 May 22
copy & paste +upvote -downvote 3 signs of pneumoperitoneum in one AXR 💡 #GITwitter #MedEd
1️⃣ Hyperlucent liver sign (*) - dark gas over the nor… https://t.co/iE5DIbX2jg
8.
9.
10.
11.
Rashid Lui 雷諾信
@RashidLui
1\ De-prescribing PPIs @AGA_Gastro
Review indication regularly
Consider trial off PPI
Consider BID … twitter.com/i/web/status/1…
Review indication regularly
Consider trial off PPI
Consider BID … twitter.com/i/web/status/1…
Retweet of status by @CatherineWangMD
19 Feb 22
copy & paste +upvote -downvote 🚨 1\ De-prescribing PPIs @AGA_Gastro
1️⃣ Review indication regularly
2️⃣ Consider trial off PPI
3️⃣ Consider BID ➡️… https://t.co/NM8kH3oKtk
Rashid Lui 雷諾信
@RashidLui
Downstaging HCC for liver transplantation
Overall, 55% success, 31% LT, 16% HCC recurrence
Baseline tumor burden… twitter.com/i/web/status/1…
Overall, 55% success, 31% LT, 16% HCC recurrence
Baseline tumor burden… twitter.com/i/web/status/1…
Retweet of status by @DrHuangDQ
16 Feb 22
copy & paste +upvote -downvote Downstaging HCC for liver transplantation
➡️Overall, 55% success, 31% LT, 16% HCC recurrence
Baseline tumor burden… https://t.co/O4etRwN3Rd
Rashid Lui 雷諾信
@RashidLui
Characteristics of common IV fluids #4KMedEd pic.twitter.com/diEN6Thf6i
Retweet of status by @drkeithsiau
05 Nov 21
copy & paste +upvote -downvote Characteristics of common IV fluids 💉💧 #4KMedEd https://t.co/diEN6Thf6i
Rashid Lui 雷諾信
@RashidLui
Off the press!
Our latest study led by @ttchantingting @Raymond_SY_Tang from @CUHKMedicine showing that fatty… twitter.com/i/web/status/1…
Our latest study led by @ttchantingting @Raymond_SY_Tang from @CUHKMedicine showing that fatty… twitter.com/i/web/status/1…
27 Sep 21
copy & paste +upvote -downvote 🔥 Off the press!
Our latest study led by @ttchantingting @Raymond_SY_Tang from @CUHKMedicine showing that fatty… https://t.co/25epTZ82BZ
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13
copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊